Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy-Reference-Cited by-同舟云学术

Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy

Published:2017-03-16 Issue:18 Volume:8 Page:29984-29995
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chang Chia-Hui¹²,Hu Ya-Hui¹,Tsai Yao-Chou³,Wu Che-Hsiung⁴,Wang Shuo-Meng⁵,Lin Lian-Yu⁶,Lin Yen-Hung⁶,Satoh Fumitoshi⁷,Wu Kwan-Dun⁸,Wu Vin-Cent⁸⁹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

2. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

3. Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

4. Division of Nephrology, Department of Internal Medicine, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

5. Division of Urology, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan

6. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

7. Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University, Graduate School of Medicine, Sendai, Japan

8. Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

9. TAIPAI, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review;Endocrine Practice;2024-07

2. Clinical Progress of Cardiovascular and Metabolic Damage Caused by KCNJ5 Mutation in Aldosterone Adenoma;Advances in Clinical Medicine;2024

3. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism;Endocrine;2023-12-12

4. Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism;Frontiers in Endocrinology;2023-03-06

5. Implication of MR Activity in Posttreatment Arterial Stiffness Reversal in Patients With Primary Aldosteronism;The Journal of Clinical Endocrinology & Metabolism;2022-11-05